tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX
Holding OCX?
Track your performance easily

OncoCyte (OCX) Financial Statements

411 Followers

OncoCyte Financial Overview

OncoCyte's market cap is currently ―. The company's EPS TTM is $-4.43; its P/E ratio is -0.52; OncoCyte is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 115.00K$ 104.00K$ 429.00K$ 463.00K$ 297.00K
Gross Profit$ 50.00K$ 50.00K$ 248.00K$ 272.00K$ 10.00K
EBIT$ -13.46M$ -4.52M$ -5.12M$ -8.32M$ 5.97M
EBITDA$ -13.12M$ -4.20M$ -4.69M$ -7.86M$ 6.44M
Net Income Common Stockholders$ -13.49M$ -4.59M$ -6.69M$ -8.64M$ 2.40K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.40M$ 9.30M$ 14.24M$ 17.87M$ 12.40M
Total Assets$ 70.22M$ 74.72M$ 81.59M$ 87.54M$ 82.85M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.40M$ -9.30M$ -14.24M$ -17.87M$ -12.40M
Total Liabilities$ 60.51M$ 52.02M$ 39.10M$ 39.22M$ 44.87M
Stockholders Equity$ 9.71M$ 22.74M$ 37.56M$ 43.60M$ 37.98M
Cash Flow-
Free Cash Flow$ -5.64M$ -6.17M$ -2.28M$ -6.71M$ -8.30M
Operating Cash Flow$ -5.55M$ -5.98M$ -2.26M$ -6.83M$ -8.30M
Investing Cash Flow$ -87.00K$ -191.00K$ -1.30M$ 123.00K$ -1.37M
Financing Cash Flow$ -255.00K$ 9.85M$ -30.00K$ 12.27M$ -28.00K
Currency in USD

OncoCyte Earnings and Revenue History

OncoCyte Debt to Assets

OncoCyte Cash Flow

OncoCyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis